Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector

Gene Therapy

Volumn 7, Issue 9, 2000, Pages 790-796

  Dupont, F ^a,d   Avalosse, B ^a   Karim, A ^a   Mine, N ^a   Bosseler, M ^a   Maron, A ^b   Van Den Broeke, A ^a   Ghanem, G E ^c   Burny, A ^d   Zeicher, M ^d  

^a Lab d'Invest Clin d'Oncol E   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Cytotoxic gene therapy; Gene expression targeting; HSV 1 thymidine kinase; MVMp based vectors; Oncotropism

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; GANCICLOVIR; GREEN FLUORESCENT PROTEIN; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; BREAST ADENOCARCINOMA; BREAST EPITHELIUM; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; GLIOMA CELL; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; NERVE CELL; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; RAT; REPORTER GENE; SIMIAN VIRUS 40; VIRUS CELL TRANSFORMATION; VIRUS RECOMBINANT;

ANIMALIA; HERPES; HUMAN HERPESVIRUS 1; MICE MINUTE VIRUS; PARVOVIRUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; SIMPLEXVIRUS;

EID: 0034021680     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301161     Document Type: Article

References (46)

1. Marcel T, Grausz JD. The TMC Worldwide Gene Therapy Enrollment Report (June 1996). Hum Gene Ther 1996; 7: 2025-2046.
2. Yee D et al. Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancer. Hum Gene Ther 1996; 7: 1251-1257.
3. Brand K et al. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther 1997; 4: 9-16.
4. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995; 9: 190-199.
5. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376.
6. Douglas JT et al. Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996; 14: 1574-1578.
7. Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
8. Miller N, Whelan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 1997; 8; 803-815.
9. Miyatake S, Iyer A, Martuza RL, Rabkin SD. Transcriptional targeting of herpes simplex virus for cell-specific replication. J Virol 1997; 71: 5124-5132.
10. Russell SJ. Lymphokine gene therapy for cancer. Immunol Today 1990; 11: 196-200.
11. Cotmore SF, Tattersall P. The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 1987; 33: 91-174.
12. Berns KI. Parvovirus replication. Microbiol Rev 1990; 54: 316-329.
13. Rommelaere J, Tattersall P. Oncosuppression by parvoviruses. In: Tijsen P (ed). Handbook of Parvoviruses. CRC Press: Boca Raton, 1990, pp 41-57.
14. Rommelaere J, Cornelis JJ. Antineoplastic activity of parvoviruses. J Virol Meth 1991; 33: 233-251.
15. Perros M et al. Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells. J Virol 1995; 69: 5506-5515.
16. Fuks F et al. ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors. J Virol 1996; 70: 1331-1339.
17. Cotmore SF, Tattersall P. DNA replication in the autonomous parvoviruses. Semin Virol 1995; 6: 271-281.
18. Doerig C, Hirt B, Beard P, Antonietti JP. Minute virus of mice non-structural protein NS-1 is necessary and sufficient for transactivation of the viral P39 promoter. J Gen Virol 1988; 69: 2563-2573.
19. Christensen J, Cotmore SF, Tattersall P. Minute virus of mice transcriptional activator protein NS1 binds directly to the trans-activation region of the viral P38 promoter in a strictly ATP-dependent manner. J Virol 1995; 69: 5422-5430.
20. Brandenburger A, Legendre D, Avalosse B, Rommelaere J. NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp. Virology 1990; 174: 576-584.
21. Caillet-Fauquet P et al. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J 1990; 9: 2989-2995.
22. Russell SJ et al. Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 1992; 66: 2821-2828.
23. Dupont F et al. Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein. J Virol 1994; 68: 1397-1406.
24. Naeger LK, Cater J, Pintel DJ. The small nonstructural protein (NS2) of the parvovirus minute virus of mice is required for efficient DNA replication and infectious virus production in a cell-type-specific manner. J Virol 1990; 64: 6166-6175.
25. Spegelaere P et al. Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene. J Virol 1991; 65: 4919-4928.
26. Rhode SL. Replication process of the parvovirus H-1. I. Kinetics in a parasynchronous cell system. J Virol 1973; 11: 856-861.
27. Siegl G, Gautschi M. The multiplication of parvovirus Lu3 in a synchronized culture system. II. Biochemical characteristics of virus replication. Arch Gesamte Virusforsch 1973; 40: 119-127.
28. Tattersall P, Bratton J. Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. J Virol 1983; 46: 944-955.
29. Deleu L et al. Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP-overexpressing cells versus serum-starved or growing cells. Mol Cell Biol 1998; 18: 409-419.
30. Maron A et al. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. Gene Therapy 1996; 3: 315-322.
31. Maron A et al. Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene. Gene Therapy 1997; 4: 25-31.
32. Siegl G. Biology and pathogenicitv of autonomous parvoviruses. In: Berns KJ (ed). The Parvoviruses. Plenum Press: New York, 1994, pp 297-348.
33. Studdert MJ. Tissue tropism of parvoviruses. In: Tijsen P (ed). Handbook of Parvoviruses. CRC Press: Boca Raton, 1990, pp 3-27.
34. Koering CE et al. Induced expression of the conditionally cytotoxic herpes simplex virus thymidine kinase gene by means of a parvoviral regulatory circuit. Hum Gene Ther 1994; 5: 457-463.
35. Lee SW et al. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 1992; 118: 1213-1221.
36. Nicolson GL. Breast cancer metastasis-associated genes: role in rumour progression to the metastatic state. Biochem Soc Symp 1998; 63: 231-243.
37. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996; 84: 381-388.
38. Bi WL, Parysek LM, Warnick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993; 4: 725-731.
39. Vrionis FD et al. The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions. Gene Therapy 1997; 4: 577-585.
40. Dilber MS et al. Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res 1997; 57: 1523-1528.
41. Rommelaere J, Ward DC. Effect of UV-irradiation on DNA replication of the parvovirus minute-virus-of-mice in mouse fibroblasts. Nucleic Acids Res 1982; 10: 2577-2596.
42. Shein HM, Enders JE. Multiplication and cytopathogenicity of simian vacuolating virus 40 in cultures of human tissue. Proc Soc Exp Biol Med 1962; 40: 495-500.
43. Heimann P et al. Chromosomal findings in cultured melanocytes from a giant congenital nevus. Cancer Genet Cytogenet 1993; 68: 74-77.
44. Merchlinsky MJ et al. Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice. J Virol 1983; 47: 227-232.
45. Colbere-Garapin F et al. Cloning of the active thymidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12. Proc Natl Acad Sci USA 1979; 76: 3755-3759.
46. Avalosse B et al. Method for concentrating and purifying recombinant autonomous parvovirus vectors designed for tumour-cell-targeted gene therapy. J Virol Meth 1996; 62: 179-183.